| Literature DB >> 29748736 |
Ulf Jonsson1,2,3, Nora Choque Olsson1,2, Christina Coco1,2, Anders Görling2, Oskar Flygare1,2, Anna Råde1,2, Qi Chen1,4, Steve Berggren1,2, Kristiina Tammimies1,2, Sven Bölte5,6.
Abstract
Social skills group training (SSGT) is widely used for intellectually able children and adolescents with autism spectrum disorder (ASD). Previous studies indicate small to moderate effects on social communication capacities. The duration of most available programs is relatively short, and extended training might lead to further improvement. This randomized controlled trial compared an extended 24-week version of the SSGT program KONTAKT with standard care. The weekly sessions gradually shifted in content from acquisition of new skills to real-world application of the acquired skills. A total of 50 participants with ASD (15 females; 35 males) aged 8-17 years were included. The study was conducted at two child and adolescent psychiatry outpatient units in Sweden. The primary outcome was the Social Responsiveness Scale-Second Edition (SRS-2) rated by parents and blinded teachers. Secondary outcomes included parent- and teacher-rated adaptive behaviors, trainer-rated global functioning and clinical severity, and self-reported child and caregiver stress. Assessments were made at baseline, posttreatment, and at 3-months follow-up. Parent-rated SRS-2 scores indicated large effects posttreatment [- 19.2; 95% CI - 29.9 to - 8.5; p < .001, effect size (ES) = 0.76], which were maintained at follow-up (- 20.7; 95% CI - 31.7 to - 9.7; p < .0001, ES = 0.82). These estimates indicate substantially larger improvement than previously reported for shorter SSGT. However, the effects on teacher-rated SRS-2 and most secondary outcomes did not reach statistical significance. Our results suggest added benefits of extended SSGT training, implying that service providers might reach better results by optimizing the delivery of SSGT.Entities:
Keywords: Autism; Group training; Long-term; Neurodevelopmental disorder; Social skills
Mesh:
Year: 2018 PMID: 29748736 PMCID: PMC6510850 DOI: 10.1007/s00787-018-1161-9
Source DB: PubMed Journal: Eur Child Adolesc Psychiatry ISSN: 1018-8827 Impact factor: 4.785
Participants’ demographic and clinical characteristics at baseline
| Participant characteristics | KONTAKT + standard care ( | Standard care ( |
|
|---|---|---|---|
| Age (years), mean (SD) | 13.04 (2.58) | 12.63 (2.83) | 0.59 |
| Males, | 18 (78%) | 17 (63%) | 0.24 |
| Language, | 0.77 | ||
| Swedish | 21 (91%) | 24 (89%) | |
| Other | 2 (9%) | 3 (11%) | |
| WISC-IV, Mean (SD) | |||
| Full-scale IQ | 98.57 (14.38) | 95.59 (9.55) | 0.39 |
| Verbal IQ | 102.78 (18.67) | 97.11 (10.09) | 0.18 |
| Performance IQ | 106.48 (11.46) | 102.67 (14.68) | 0.32 |
| Working memory | 86.43 (13.47) | 91.78 (12.15) | 0.15 |
| Processing speed | 93.70 (16.31) | 90.85 (11.60) | 0.48 |
| ADOS, mean (SD) | |||
| Total score | 10.83 (3.45) | 11.19 (3.13) | 0.70 |
| Communication | 3.22 (1.31) | 3.59 (1.72) | 0.40 |
| Reciprocal social interaction | 7.61 (2.74) | 7.59 (2.02) | 0.98 |
| ASD diagnosis, | 0.21 | ||
| Autistic disorder | 1 (4%) | 3 (11%) | |
| Asperger’s syndrome | 14 (61%) | 20 (74%) | |
| PDD-NOS | 8 (35%) | 4 (15%) | |
| Comorbidity, | |||
| ADHD | 16 (70%) | 18 (67%) | 0.83 |
| Anxiety | 6 (26%) | 7 (26%) | 0.99 |
| Depression | 8 (35%) | 5 (19%) | 0.19 |
| Other | 2 (9%) | 4 (15%) | 0.51 |
| Pharmacological treatment, | |||
| Stimulants | 9 (39%) | 15 (56%) | 0.25 |
| Sleep inducing | 4 (17%) | 3 (11%) | 0.52 |
| SSRI | 7 (30%) | 9 (33%) | 0.83 |
| Anti-histamine | 8 (35%) | 4 (15%) | 0.10 |
| Anti-psychotic | 1 (4%) | 2 (7%) | 0.65 |
| Anti-epileptic | 0 | 0 | – |
| Benzodiazepines | 0 | 1 (4%) | 0.35 |
| Psychological treatment, | |||
| CBT | 0 | 1 (4%) | 0.35 |
| Counseling | 1 (4%) | 2 (7%) | 0.65 |
| Habilitation services, | |||
| Parental psychoeducation | 3 (13%) | 2 (7%) | 0.51 |
| Other (e.g., cognitive aids, heavy weighted blankets) | 4 (17%) | 0 | 0.02 |
| SRS-2 (parent), mean (SD) | 91.13 (30.75) | 88.96 (20.27) | 0.77 |
| SRS-2 (teacher), mean (SD) | 69.14 (32.84) | 73.16 (26.32) | 0.67 |
CBT cognitive behavior therapy, WISC-IV Wechsler Intelligence Scale for Children 4th Edition, ADOS autism diagnostic observation schedule, ASD autism spectrum disorder, PDD-NOS pervasive developmental disorder not otherwise specified, ADHD attention-deficit hyperactivity disorder, SSRI selective serotonin reuptake inhibitor, SRS-2 Social Responsiveness Scale 2nd Edition
Fig. 1CONSORT Flow Diagram. *The number of participants assessed refer to parent-rated outcome measures
Characteristics of the participating parents
| Parental characteristics | KONTAKT + standard care ( | Standard care ( |
|
|---|---|---|---|
| Relationship to participant, | 0.51 | ||
| Mother | 16 (70%) | 21 (78%) | |
| Father | 7 (30%) | 6 (22%) | |
| Age (years), mean (SD) | 47.43 (5.95) | 48.52 (4.30) | 0.46 |
| Marital status, | 0.30 | ||
| Cohabiting | 18 (78%) | 17 (63%) | |
| Living apart | 0 | 2 (7) | |
| Single parent | 5 (22%) | 8 (30%) | |
| No. of children, | 0.29 | ||
| 1 | 2 (9%) | 7 (26%) | |
| 2 | 13 (57%) | 13 (48%) | |
| 3 | 8 (35%) | 6 (22%) | |
| 4+ | 0 | 1 (4%) | |
| Occupation of parent, | 0.56 | ||
| Full-time work | 13 (57%) | 15 (56%) | |
| Part-time work | 7 (30%) | 5 (19%) | |
| Student | 0 | 1 (4%) | |
| Looking for work | 0 | 0 | |
| Sick leave | 2 (9%) | 2 (7%) | |
| Other | 1 (4%) | 4 (15%) | |
| Education (years), mean (SD) | 15.63 (2.23) | 14.59 (2.03) | 0.22 |
Primary outcome measures at baseline, week 24/posttreatment and 3-months follow-up
| Measure | Mean (95% CI)a | Group difference in change score |
| Effect size (95% CI)b | |
|---|---|---|---|---|---|
| KONTAKT + standard care ( | Standard care ( | ||||
| SRS-2 (parent) | |||||
| Baseline | 91.1 (80.7–101.6) | 89.0 (79.3–98.6) | |||
| Posttreatment | 74.3 (63.1–85.5) | 91.3 (81.5–101.1) | − 19.2 (− 29.9 to − 8.5) | 0.001 | 0.76 (0.18–1.34) |
| Follow-up | 68.5 (57.2–79.8) | 87.0 (77.1–96.9) | − 20.7 (− 31.7 to − 9.7) | 0.0001 | 0.82 (0.24–1.40) |
| SRS-2 (teacher) | |||||
| Baseline | 68.9 (57.5–80.3) | 72.9 (60.9–84.9) | |||
| Posttreatment | 55.0 (39.0–71.1) | 73.9 (61.1–86.7) | − 14.9 (− 34.5 to 5) | 0.15 | 0.50 (− 0.06 to 1.06) |
| Follow-up | 59.0 (44.6–73.3) | 70.7 (56.9–84.5) | − 7.7 (− 26.8 to 11.8) | 0.45 | 0.26 (− 0.30 to 0.82) |
SRS-2 Social Responsiveness Scale 2nd Edition
a Data are presented as raw mean scores at baseline and least squares mean values for week 24/posttreatment and 3 months follow-up with 95% CIs for each assessment point
b Effect sizes were calculated by taking the difference in the least squares means at 24 week/posttreatment and follow-up dividing by the pooled standard deviation at baseline; positive effect sizes favor KONTAKT
Fig. 2Least square means and 95% confidence intervals for parent- and teacher-rated Social Responsiveness Scale–Second Edition (SRS-2) scores at baseline, posttreatment and 3-month follow-up; significant time by group interactions are indicated by p-values
Secondary outcome measures at baseline, week 24/posttreatment and 3-months follow-up
| Measure (rater) | Mean (95% CI)a | Group difference in change score |
| Effect size (95% CI)b | |
|---|---|---|---|---|---|
| KONTAKT + standard care ( | Standard care ( | ||||
| ABAS-II (parent) | |||||
| Baseline | 388.0 (361.3–414.8) | 376.0 (351.3–400.7) | |||
| Posttreatment | 411.6 (383.6–439.6) | 386.5 (361.5–411.5) | 13.1 (− 8.5 to 34.7) | 0.25 | 0.19 (− 0.37 to 0.75) |
| Follow-up | 427.2 (399.0–455.5) | 399.1 (373.9–424.3) | 16.1 (− 6 to 38.3) | 0.16 | 0.24 (− 0.32 to 0.80) |
| ABAS-II (teacher) | |||||
| Baseline | 361.1 (330.9–391.3) | 339.0 (308.0–370.0) | |||
| Posttreatment | 386.2 (350.6–421.8) | 344.2 (312.2–376.2) | 19.9 (− 13.9 to 53.6) | 0.27 | 0.26 (− 0.30 to 0.82) |
| Follow-up | 379.3 (345.7–413.0) | 349.6 (316.7–382.5) | 7.6 (− 26.1 to 41.0) | 0.67 | 0.10 (− 0.46 to 0.66) |
| DD-CGAS (trainer) | |||||
| Baseline | 56.0 (52.9–59.1) | 56.4 (53.5–59.2) | |||
| Posttreatment | 60.6 (57–64.2) | 55.7 (52.8–58.7) | 5.2 (0.2–10.2) | 0.046 | 0.83 (0.25–1.41) |
| Follow-up | 60 (56.6–63.4) | 58.6 (55.7–61.4) | 1.8 (− 3.1 to 6.6) | 0.48 | 0.29 (− 0.27 to 0.85) |
| CGI-S (trainer) | |||||
| Baseline | 4.3 (4.0–4.7) | 4.5 (4.2–4.8) | |||
| Posttreatment | 4.1 (3.7–4.4) | 4.4 (4.1–4.7) | − 0.2 (− 0.7 to 0.4) | 0.56 | 0.31(− 0.25 to 0.87) |
| Follow-up | 3.9 (3.6–4.3) | 4.0 (3.7–4.3) | 0.1 (− 0.5 to 0.6) | 0.83 | − 0.16 (− 0.72 to 0.40) |
| CiS (child self-report) | |||||
| Baseline | 2.4 (2.2–2.6) | 2.3 (2.2–2.5) | |||
| Posttreatment | 2.4 (2.2–2.7) | 2.3 (2.1–2.5) | 0.1 (− 0.1 to 0.3) | 0.45 | − 0.20 (− 0.76 to 0.36) |
| Follow-up | 2.4 (2.1–2.6) | 2.3 (2.1–2.5) | 0.0 (− 0.2 to 0.2) | 0.90 | 0.00 (− 0.56 to 0.56) |
| PSS (parental self-report) | |||||
| Baseline | 26.3 (22.9–29.6) | 25.9 (22.8–29.0) | |||
| Posttreatment | 20.1 (16.3–24) | 23.4 (20.2–26.6) | − 3.6 (− 8.3 to 1.0) | 0.14 | 0.46 (− 0.10 to 1.02) |
| Follow-up | 19.1 (15.3–23) | 21.6 (18.4–24.9) | − 2.8 (− 7.5 to 1.8) | 0.24 | 0.36 (− 0.20 to 0.92) |
ABAS-II adaptive behavior assessment system II, CGI-S OSU Autism Clinical Global Impression—Severity, CiS children in stress, DD-CGAS, developmental disabilities modification of the Children’s Global Assessment Scale, PSS Perceived Stress Scale
a Data are presented as raw mean scores at baseline and least squares mean values for week 12/posttreatment and 3 months follow-up with 95% CIs for each assessment point
b Effect sizes were calculated by taking the difference in the least squares means at 24 week/posttreatment and follow-up dividing by the pooled standard deviation at baseline; positive effect sizes favor KONTAKT